DNA RNA and Cells
22 January 2024
Strand Therapeutics Receives IND Clearance for Programmable mRNA Therapy STX-001 to Treat Solid Tumors18 January 2024
Alaya.bio announces significant collaboration with leading global cancer center to advance in situ CAR-T Therapy17 January 2024
VRG Therapeutics announces successful in vivo efficacy results of their CAR-T project targeting glioblastoma17 January 2024
Vertex Announces US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Transfusion-Dependent Beta Thalassemia12 January 2024
Indapta Therapeutics Announces First Patients Treated with IDP-023 Allogeneic Natural Killer (NK) Cell Therapy for Cancer9 January 2024
GC Cell’s Promising AB-201 Cancer Treatment to Begin Phase 1 Trials Using Lunit AI Platform6 January 2024
AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF)5 January 2024
AbbVie and Umoja Biopharma Announce Strategic Collaboration to Develop Novel In-Situ CAR-T Cell TherapiesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports